Profil
Scott Kahn is currently the Chief Financial Officer at HWEL Holdings Corp.
He previously worked as the Chief Financial Officer at Milestone Scientific, Inc. for a brief period in 2021.
Prior to that, he was the Chief Financial Officer & Vice President at Diopsys, Inc. and the Chief Financial Officer at Milestone Medical, Inc. Mr. Kahn holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Franklin & Marshall College.
Postes actifs de Scott Kahn
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Scott Kahn
| Sociétés | Poste | Fin |
|---|---|---|
| MILESTONE SCIENTIFIC INC. | Director of Finance/CFO | 02/07/2021 |
Diopsys, Inc.
 Diopsys, Inc. Medical SpecialtiesHealth Technology Diopsys, Inc. develops and manufactures medical instruments. The firm's product Enfant is a pediatric vision testing system and non-invasive medical device that is used to test for visual deficits in pre-verbal children. The company was founded in 1983 and is headquartered in Pine Brook, NJ. | Director of Finance/CFO | - |
| MILESTONE MEDICAL, INC. | Director of Finance/CFO | - |
Formation de Scott Kahn
| Rutgers State University of New Jersey | Masters Business Admin |
| Franklin & Marshall College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MILESTONE SCIENTIFIC INC. | Health Technology |
| MILESTONE MEDICAL, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Diopsys, Inc.
Diopsys, Inc. Medical SpecialtiesHealth Technology Diopsys, Inc. develops and manufactures medical instruments. The firm's product Enfant is a pediatric vision testing system and non-invasive medical device that is used to test for visual deficits in pre-verbal children. The company was founded in 1983 and is headquartered in Pine Brook, NJ. | Health Technology |
